Penumbra, Inc. Ready to Showcase Innovations at Major Investor Conferences

Penumbra, Inc., a leader in thrombectomy innovation, is gearing up to present at several significant investor conferences this June 2025. The company is known for its cutting-edge technology aimed at treating complex medical conditions, including ischemic stroke and venous thromboembolism. Here’s what to expect from their upcoming presentations.

Conference Schedule

1. William Blair 45th Annual Growth Stock Conference
- Date: Tuesday, June 3, 2025
- Time: 3:00 PM ET / 12:00 PM PT

2. Jefferies Global Healthcare Conference
- Date: Wednesday, June 4, 2025
- Time: 9:55 AM ET / 6:55 AM PT

3. Truist Securities MedTech Conference
- Date: Tuesday, June 17, 2025
- Time: 10:00 AM ET / 7:00 AM PT

These conferences represent a critical platform for Penumbra to share its vision and innovations with investors, industry experts, and stakeholders. Through these presentations, the company aims to highlight its advancements and commitment to enhancing healthcare solutions worldwide.

Access to Presentations

Investors and interested parties can follow the live webcasts of these events, available on the company’s website under the “Events and Presentations” section. These sessions will also be accessible for two weeks afterward, allowing viewers to revisit insights and discussions led by Penumbra’s management team.

About Penumbra, Inc.

Penumbra is at the forefront of thrombectomy technology, dedicated to addressing difficult medical challenges. The company’s innovative solutions are designed for conditions such as ischemic stroke, pulmonary embolism, and acute limb ischemia.

With a mission to improve patient outcomes and quality of life, Penumbra’s extensive portfolio includes advanced computer-assisted vacuum thrombectomy (CAVT) systems designed for effective clot removal with safety and simplicity in mind.

Penumbra serves healthcare providers and facilities in over 100 countries, exhibiting a strong global presence in the medical technology space. The company’s commitment to innovation and excellence underscores its leadership in thrombectomy and ongoing dedication to the healthcare community.

Connecting with Penumbra

To stay updated on Penumbra’s latest developments and innovations, follow the company on social media platforms such as Instagram, LinkedIn, and X. Additionally, information about new product launches, research initiatives, and corporate strategies can be found on their official website at www.penumbrainc.com.

In summary, Penumbra, Inc. will present at key investor conferences throughout June 2025, showcasing its leadership in thrombectomy technology and its ongoing commitment to advancing medical care. With its innovative approach and dedication to improving healthcare, Penumbra remains a vital player in the field of medical technology.